Cataract Surgery on Advanced Age Related Macular Degeneration Patients

Sponsor
University of British Columbia (Other)
Overall Status
Withdrawn
CT.gov ID
NCT04045704
Collaborator
(none)
0
2

Study Details

Study Description

Brief Summary

The degree at which cataract surgery improves visual function in patients with advanced age-related macular degeneration (Advanced AMD) has been an on-going topic of discussion. Our objective in this study is to determine if patients with Advanced AMD and concurrent cataracts will experience greater improvement in their quality of life from having cataract surgery on one or both eyes. The findings from this project will provide evidence for clinical decision making on whether performing bilateral cataract surgery on Advanced AMD patients is cost-effective and worth the second surgical intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Cataract Surgery
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effects of Unilateral and Bilateral Cataract Extraction on Visual Function of Advanced Age-Related Macular Degeneration Patients.
Anticipated Study Start Date :
Oct 1, 2019
Anticipated Primary Completion Date :
Dec 1, 2019
Anticipated Study Completion Date :
Dec 1, 2019

Outcome Measures

Primary Outcome Measures

  1. Life style Questionnaire to determine change in visual function. [Through study completion, an average of 1 year]

    Our primary outcome will be a life style questionnaire (qualitative) to determine the change in visual function from baseline to after surgery. This questionnaire includes 25 close-ended questions that are graded on a 5 point grading scale from 1 (great difficulty due to vision) and 5 (no problem due to vision). The questions can also be graded as not applicable to an individuals life, or 0 being something there are no longer possible to do, due to vision. The 25 close-ended questions are divided into 4 sub-scales: Distance Vision, Mobility, and Lighting (Q: 1-12) Adjustment (Q:13-16) Reading and Fine Work (Q: 17-21) Activities of Daily Living (Q: 22-25) A total score can range from a 125 indicating best visual function to 0 indicating complete loss of visual function.

Secondary Outcome Measures

  1. Snellens Chart to determine change in visual acuity [Through study completion, an average of 1 year]

    Quantitative measure of a patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.

  2. Auto Refractive to determine change in visual acuity [Through study completion, an average of 1 year]

    An auto-refractor is a computerized machine to measure patients visual acuity. Change from baseline visual acuity to after surgery on both eyes.

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Patients above the age of fifty with both Advanced AMD and Cataracts bilaterally from the Okanagan Valley will be selected for this study.

Patients who chose to have bilateral cataract surgery, were able to understand the research parameters, and had no other severe eye disease that may distort the studies results.

Patients will be selected for the study according to the National Eye Institute definition of Advanced AMD.

"Advanced AMD (AREDS category 4) is characterized by one or more of the following (in the absence of other causes) in one eye:

Geographic atrophy of the RPE involving the foveal center.

Neovascular maculopathy that includes the following:
  • Choroidal neovascularization (CNV) defined as pathologic angiogenesis originating from the choroidal vasculature that extends through a defect in Bruch's membrane

  • Serous and/or hemorrhagic detachment of the neurosensory retina or RPE

  • Retinal hard exudates (a secondary phenomenon resulting from chronic intravascular leakage)

  • Subretinal and sub-RPE fibrovascular proliferation

  • Disciform scar (subretinal fibrosis)"

Exclusion Criteria:
  • Severe intraoperative or postoperative complications such as retinal detachments, and capsule ruptures

  • Inability to complete the required testing (auto-refractive and visual acuity)

  • Inability to attend appointments

  • Inability to complete the questionnaire with Co-I assistance

  • Severe eye disease that may distort the studies results such as but not limited to Epithelial Basement Membrane Dystrophy (EBMD) and retinal detachments.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of British Columbia

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jeffrey Chambers, Clinical Assistant Professor, University of British Columbia
ClinicalTrials.gov Identifier:
NCT04045704
Other Study ID Numbers:
  • H19-00830
First Posted:
Aug 5, 2019
Last Update Posted:
Oct 4, 2021
Last Verified:
Sep 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 4, 2021